U.S. markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • Gold

    1,753.90
    -2.80 (-0.16%)
     
  • Silver

    22.36
    -0.43 (-1.90%)
     
  • EUR/USD

    1.1732
    -0.0040 (-0.34%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.43%)
     
  • USD/JPY

    109.8950
    +0.1770 (+0.16%)
     
  • BTC-USD

    48,394.75
    +1,459.13 (+3.11%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

STERIS' (STE) Organic Growth Robust Amid Bottom-Line Hurdles

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

On Mar 30, we issued an updated research report on STERIS plc STE. The company has been actively trying to expand into the adjacent markets, and foritfy its core business through acquisitions and divestments. However, a tough competitive landscape and currency headwinds persistently pose threats to STERIS. The stock currently carries a Zacks Rank #2 (Buy).

Over the past three months, shares of STERIS have outperformed its industry. The stock has declined 14.9% compared with the 16.2% fall of the industry.

In the last reported quarter, the company witnessed solid revenue growth across each of its operating segments, which is encouraging.

Healthcare Products, Healthcare Specialty Services, Applied Sterilization Technologies and Life Sciences segments registered growth of 8%, 12.6%, 14.3% and 16.4%, respectively.

STERIS is currently displaying stellar top-line performance on favorable underlying market trends, along with new product and service offerings. The company’s service maintenance revenues recorded growth, primarily driven by installation revenues owing to solid capital shipments, in the first half of fiscal 2020.

STERIS plc Price

STERIS plc Price
STERIS plc Price

STERIS plc price | STERIS plc Quote

STERIS has also made certain acquisitions and organizational changes, which are anticipated to better align with its operations. With the acquisition of the U.K.-based outsourced sterilization services provider — Synergy Health — STERIS has become the latest global leader in infection prevention and sterilization.

Meanwhile, escalating operating expenses are straining the bottom line. A decline in free cash flow mainly due to increased capital spending and adverse foreign-exchange impact on revenues are concerning. Also, STERIS competes for pharmaceutical, research and industrial customers with several bigwigs with extensive product portfolios and global reach.

Further, the ongoing economic crisis in the wake of the coronavirus outbreak is significantly affecting share price.

Other Key Picks

Some other top-ranked stocks in the broader medical space are ResMed Inc. RMD, Medtronic plc MDT and Hill-Rom Holdings, Inc HRC.

ResMed has a projected long-term earnings growth rate of 12%. It currently carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Medtronic’s long-term earnings growth rate is estimated at 7.4%. The company presently carries a Zacks Rank of 2.

Hill-Rom’s long-term earnings growth rate is projected at 11.1%. It currently carries a Zacks Rank #2.

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?

Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2020 today >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Medtronic PLC (MDT) : Free Stock Analysis Report
 
ResMed Inc. (RMD) : Free Stock Analysis Report
 
Hill-Rom Holdings, Inc. (HRC) : Free Stock Analysis Report
 
STERIS plc (STE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research